Bankers to cash in on China's SOE reforms

Reform of China’s sprawling state-owned enterprises is generating lucrative assignments for bankers. However they must be in it for the long-haul as change will take time.
July 16, 2014

China's SOE reform gathers pace

Sinopharm and China National Building Materials are next in line for further privatization as Beijing revamps its debt-laden state sector.
July 15, 2014

Sinopharm sets price range for $1.13 billion IPO

The Chinese distributor of pharmaceutical products will be the first company to take orders for a Hong Kong listing after the summer and has set the price range at HK12.25 to HK$16 per share.
September 03, 2009